Systematic Review on Persistence of Infection-Associated Urticaria in Children and Adults

Five studies involving 596 participants were included in this systematic review on long-term outcomes of infection-associated urticaria. The review, conducted by Saad Alhumaid and registered in PROSPERO, synthesizes evidence on symptom persistence, recurrence, and progression to chronic disease. It was last updated on 2026-05-26.

Use Cases

• Estimating rates of chronic urticaria development based on reported persistence beyond 6 months.
• Analyzing risk patterns for delayed-onset urticaria following SARS-CoV-2 infection as described in the review.
• Comparing recurrence rates of infection-associated urticaria across different viral etiologies.
• Identifying gaps in evidence for pathogen-specific analyses of urticaria outcomes.

Strengths

• Follows PRISMA 2020 guidelines and is prospectively registered in PROSPERO (CRD420261319656).
• Includes data from five studies with a total of 596 participants.
• Risk of bias assessment was performed independently by two reviewers using the Newcastle–Ottawa Scale.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small (18.3 KB), indicating limited scope.
• The review notes evidence is limited by heterogeneous study designs and mixed aetiologies.

Provenance

Source

Saad Alhumaid via figshare.

Collection Method

Systematic review of observational studies from PubMed, Embase, CINAHL, Scopus, and Web of Science.

Time Range

Literature search from database inception to 17 March 2026.

Freshness

Last updated 2026-05-26 06:03:38; freshness should be verified.